LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 81

Search options

  1. Article: Does amantadine have a protective effect against COVID-19?

    Cortés Borra, Albert

    Neurologia i neurochirurgia polska

    2020  Volume 54, Issue 3, Page(s) 284–285

    MeSH term(s) Amantadine/therapeutic use ; Betacoronavirus ; COVID-19 ; Coronavirus Infections/drug therapy ; Humans ; Pandemics ; Pneumonia, Viral/drug therapy ; SARS-CoV-2
    Chemical Substances Amantadine (BF4C9Z1J53)
    Keywords covid19
    Language English
    Publishing date 2020-06-04
    Publishing country Poland
    Document type Journal Article
    ZDB-ID 415519-1
    ISSN 1897-4260 ; 0028-3843
    ISSN (online) 1897-4260
    ISSN 0028-3843
    DOI 10.5603/PJNNS.a2020.0041
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Book ; Online: Does amantadine have a protective effect against COVID-19?

    Cortés Borra, Albert

    Neurologia i Neurochirurgia Polska; Vol 54, No; 284-285

    2020  Volume 3

    Keywords covid19
    Language English
    Publishing date 2020-06-30
    Publisher Via Medica
    Publishing country pl
    Document type Book ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article: Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2.

    Cortés-Borra, Albert / Aranda-Abreu, Gonzalo Emiliano

    Pharmacological reports : PR

    2021  Volume 73, Issue 3, Page(s) 962–965

    Abstract: Background: Amantadine is a drug that can help in the prevention of SARS-CoV-2 symptomatology, as has been demonstrated in observational clinical studies.: Methods: We searched in the PubMed database Clinical Studies of coronavirus-infected patients ... ...

    Abstract Background: Amantadine is a drug that can help in the prevention of SARS-CoV-2 symptomatology, as has been demonstrated in observational clinical studies.
    Methods: We searched in the PubMed database Clinical Studies of coronavirus-infected patients who have been treated with amantadine in a preventive manner as well as patients with Parkinson's disease.
    Results: Four clinical studies were found in which relatives of patients with COVID-19 had been prescribed the use of amantadine in a preventive manner to avoid the symptoms caused by the coronavirus.
    Conclusion: Amantadine is a drug that can be prescribed as a prophylactic that prevents symptomatology caused by SARS-CoV-2 coronavirus.
    MeSH term(s) Amantadine/therapeutic use ; Antiviral Agents/therapeutic use ; COVID-19/drug therapy ; Humans ; SARS-CoV-2/drug effects
    Chemical Substances Antiviral Agents ; Amantadine (BF4C9Z1J53)
    Language English
    Publishing date 2021-02-18
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2186248-5
    ISSN 1734-1140
    ISSN 1734-1140
    DOI 10.1007/s43440-021-00231-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Distinct Clinical Features and Outcomes in Motor Neuron Disease Associated with Behavioural Variant Frontotemporal Dementia.

    Cortés-Vicente, Elena / Turon-Sans, Janina / Gelpi, Ellen / Clarimón, Jordi / Borrego-Écija, Sergi / Dols-Icardo, Oriol / Illán-Gala, Ignacio / Lleó, Alberto / Illa, Isabel / Blesa, Rafael / Al-Chalabi, Ammar / Rojas-García, Ricard

    Dementia and geriatric cognitive disorders

    2018  Volume 45, Issue 3-4, Page(s) 220–231

    Abstract: Aim: To determine the motor phenotype and outcome in a clinically ascertained group of patients with motor neuron disease (MND) and frontotemporal dementia (FTD).: Methods: This is an observational retrospective clinical study of patients fulfilling ... ...

    Abstract Aim: To determine the motor phenotype and outcome in a clinically ascertained group of patients with motor neuron disease (MND) and frontotemporal dementia (FTD).
    Methods: This is an observational retrospective clinical study of patients fulfilling the clinical criteria for MND-FTD. A contemporary series of patients with amyotrophic lateral sclerosis (ALS) without dementia were included for comparison. Demographic, clinical, genetic, and neuropathological data were collected. A descriptive and comparative data analysis was performed.
    Results: We identified 22 patients with MND-FTD. Selective distal upper limb muscle weakness and atrophy with non-significant lower limb weakness during follow-up was the most frequent motor pattern, present in 18 patients - in 15 of them associated with severe dysphagia. Aspiration pneumonia was the most common cause of death (12/19; 63%) despite gastrostomy. One-third of the patients did not develop upper motor neuron dysfunction. When compared to classic ALS without dementia (n = 162), these features were significantly different. A neuro-pathological examination was performed on 7 patients, and it confirmed the presence of MND with TDP43 protein aggregates in all patients.
    Conclusions: The MND-FTD patients frequently displayed a distinctive motor pattern characterized by weakness and atrophy in distal upper limb muscles and dysphagia, with no or little spreading to other regions. These features may help to define specific subgroups of patients, which is important with regard to clinical management, outcome, and research.
    MeSH term(s) Aged ; Amyotrophic Lateral Sclerosis/diagnosis ; Amyotrophic Lateral Sclerosis/physiopathology ; Amyotrophic Lateral Sclerosis/psychology ; Behavioral Symptoms/diagnosis ; DNA-Binding Proteins/genetics ; Female ; Frontotemporal Dementia/diagnosis ; Frontotemporal Dementia/genetics ; Frontotemporal Dementia/physiopathology ; Frontotemporal Dementia/psychology ; Humans ; Male ; Middle Aged ; Motor Neuron Disease/diagnosis ; Motor Neuron Disease/genetics ; Motor Neuron Disease/physiopathology ; Motor Neuron Disease/psychology ; Muscle Weakness/diagnosis ; Outcome Assessment, Health Care ; Patient Care Management/methods ; Retrospective Studies ; Upper Extremity/pathology ; Upper Extremity/physiopathology
    Chemical Substances DNA-Binding Proteins
    Language English
    Publishing date 2018-06-08
    Publishing country Switzerland
    Document type Journal Article ; Observational Study ; Research Support, Non-U.S. Gov't
    ZDB-ID 1026007-9
    ISSN 1421-9824 ; 1013-7424
    ISSN (online) 1421-9824
    ISSN 1013-7424
    DOI 10.1159/000488528
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Distinct Clinical Features and Outcomes in Motor Neuron Disease Associated with Behavioural Variant Frontotemporal Dementia

    Cortés-Vicente, Elena / Turon-Sans, Janina / Gelpi, Ellen / Clarimón, Jordi / Borrego-Écija, Sergi / Dols-Icardo, Oriol / Illán-Gala, Ignacio / Lleó, Alberto / Illa, Isabel / Blesa, Rafael / Al-Chalabi, Ammar / Rojas-García, Ricard

    Dementia and Geriatric Cognitive Disorders

    2018  Volume 45, Issue 3-4, Page(s) 220–231

    Abstract: Aim: To determine the motor phenotype and outcome in a clinically ascertained group of patients with motor neuron disease (MND) and frontotemporal dementia (FTD). Methods: This is an observational retrospective clinical study of patients fulfilling the ... ...

    Institution Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain
    Center for Networked Biomedical Research into Rare Diseases (CIBERER), Madrid, Spain
    Neurological Tissue Bank of the Biobanc Hospital Clínic IDIBAPS, Barcelona, Spain
    Institute of Neurology, Medical University of Vienna, Vienna, Austria
    Memory Unit, Department of Neurology, and Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain
    Center for Networked Biomedical Research into Neurodegenerative Diseases (CIBERNED), Madrid, Spain
    Alzheimer and Other Cognitive Disorders Unit, Department of Neurology, Hospital Clinic of Barcelona, Barcelona, Spain
    Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, King’s College London, London, United Kingdom
    Abstract Aim: To determine the motor phenotype and outcome in a clinically ascertained group of patients with motor neuron disease (MND) and frontotemporal dementia (FTD). Methods: This is an observational retrospective clinical study of patients fulfilling the clinical criteria for MND-FTD. A contemporary series of patients with amyotrophic lateral sclerosis (ALS) without dementia were included for comparison. Demographic, clinical, genetic, and neuropathological data were collected. A descriptive and comparative data analysis was performed. Results: We identified 22 patients with MND-FTD. Selective distal upper limb muscle weakness and atrophy with non-significant lower limb weakness during follow-up was the most frequent motor pattern, present in 18 patients – in 15 of them associated with severe dysphagia. Aspiration pneumonia was the most common cause of death (12/19; 63%) despite gastrostomy. One-third of the patients did not develop upper motor neuron dysfunction. When compared to classic ALS without dementia (n = 162), these features were significantly different. A neuro­pathological examination was performed on 7 patients, and it confirmed the presence of MND with TDP43 protein aggregates in all patients. Conclusions: The MND-FTD patients frequently displayed a distinctive motor pattern characterized by weakness and atrophy in distal upper limb muscles and dysphagia, with no or little spreading to other regions. These features may help to define specific subgroups of patients, which is important with regard to clinical management, outcome, and research.
    Keywords Frontotemporal dementia ; Neuropathology ; Clinical aspects ; Genetics of neurodegenerative diseases ; Amyotrophic lateral sclerosis
    Language English
    Publishing date 2018-06-08
    Publisher S. Karger AG
    Publishing place Basel, Switzerland
    Document type Article
    Note Original Research Article
    ZDB-ID 1026007-9
    ISSN 1421-9824 ; 1420-8008 ; 1013-7424
    ISSN (online) 1421-9824
    ISSN 1420-8008 ; 1013-7424
    DOI 10.1159/000488528
    Database Karger publisher's database

    More links

    Kategorien

  6. Article ; Online: Amenazas, desafíos y oportunidades para la salud medioambiental pediátrica en Europa, América Latina y el Caribe.

    Ortega-García, Juan Antonio / Tellerías, Lydia / Ferrís-Tortajada, Josep / Boldo, Elena / Campillo-López, Ferran / van den Hazel, Peter / Cortes-Arancibia, Sandra / Ramis, Rebeca / Gaioli, Marisa / Monroy-Torres, Rebeca / Farias-Guardia, Constanza / Borras, Mirta / Yohannessen, Karla / García-Noriega-Fernández, Marcelino / Cárceles-Álvarez, Alberto / Jaimes-Vega, Diana Carolina / Cordero-Rizo, Marcia / López-Hernández, Fernando / Claudio, Luz

    Anales de pediatria

    2018  Volume 90, Issue 2, Page(s) 124.e1–124.e11

    Abstract: In a world that is increasingly technological and interconnected, but also more violent, overexploited and polluted, Paediatric Environmental Health (PEH) is one of the best contributions to improve global health. Few areas of the planet have a high ... ...

    Title translation Threats, challenges and opportunities for paediatric environmental health in Europe, Latin America and the Caribbean.
    Abstract In a world that is increasingly technological and interconnected, but also more violent, overexploited and polluted, Paediatric Environmental Health (PEH) is one of the best contributions to improve global health. Few areas of the planet have a high affinity with common values and interests, such as the European Union (EU), Latin America and the Caribbean (LAC). The investments and actions of the PEH in pre- and postnatal periods during the first two decades of life will generate countless benefits in the health and well-being during the human life span. Detecting, reducing, or eliminating physical, chemical, biological and social pollutants is one of the main missions and actions of the PEH. In this special article, an update review is presented on the threats, challenges and cooperation opportunities in PEH among bio-health professionals and other social sectors involved, from the EU and LAC. New professional profiles, knowledge structures and architectures for engagement emerge. Courageous leaderships, new substantial resources, broad social changes, and the necessary collaboration between the two regions will be required to improve the health of present and future generations.
    MeSH term(s) Adolescent ; Adolescent Health ; Capacity Building ; Caribbean Region ; Child ; Child Health ; Child, Preschool ; Environmental Health/methods ; Environmental Pollution/adverse effects ; Environmental Pollution/prevention & control ; Europe ; Global Health ; Humans ; Infant ; Infant, Newborn ; Latin America ; Professional Role ; Social Change ; Young Adult
    Language Spanish
    Publishing date 2018-12-23
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2830901-7
    ISSN 2341-2879 ; 2341-2879
    ISSN (online) 2341-2879
    ISSN 2341-2879
    DOI 10.1016/j.anpedi.2018.11.015
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: BIM-23A760 influences key functional endpoints in pituitary adenomas and normal pituitaries: molecular mechanisms underlying the differential response in adenomas.

    Ibáñez-Costa, Alejandro / López-Sánchez, Laura M / Gahete, Manuel D / Rivero-Cortés, Esther / Vázquez-Borrego, Mari C / Gálvez, María A / de la Riva, Andrés / Venegas-Moreno, Eva / Jiménez-Reina, Luis / Moreno-Carazo, Alberto / Tinahones, Francisco J / Maraver-Selfa, Silvia / Japón, Miguel A / García-Arnés, Juan A / Soto-Moreno, Alfonso / Webb, Susan M / Kineman, Rhonda D / Culler, Michael D / Castaño, Justo P /
    Luque, Raúl M

    Scientific reports

    2017  Volume 7, Page(s) 42002

    Abstract: Chimeric somatostatin/dopamine compounds such as BIM-23A760, an sst2/sst5/ ... ...

    Abstract Chimeric somatostatin/dopamine compounds such as BIM-23A760, an sst2/sst5/D
    MeSH term(s) Adenoma/metabolism ; Adolescent ; Adult ; Aged ; Animals ; Apoptosis ; Calcium Signaling ; Cell Survival ; Cells, Cultured ; Dopamine/analogs & derivatives ; Dopamine/pharmacology ; Dopamine Agonists/pharmacology ; Exocytosis ; Female ; Humans ; Male ; Middle Aged ; Papio ; Pituitary Gland/cytology ; Pituitary Gland/drug effects ; Pituitary Gland/metabolism ; Pituitary Neoplasms/metabolism ; Receptors, Dopamine/genetics ; Receptors, Dopamine/metabolism ; Receptors, Somatostatin/genetics ; Receptors, Somatostatin/metabolism ; Somatostatin/analogs & derivatives ; Somatostatin/pharmacology
    Chemical Substances Dopamine Agonists ; Receptors, Dopamine ; Receptors, Somatostatin ; Somatostatin (51110-01-1) ; TBR-760 (L32IM11DV4) ; Dopamine (VTD58H1Z2X)
    Language English
    Publishing date 2017-02-09
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/srep42002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: First-in-class inhibitor of the T cell receptor for the treatment of autoimmune diseases.

    Borroto, Aldo / Reyes-Garau, Diana / Jiménez, M Angeles / Carrasco, Esther / Moreno, Beatriz / Martínez-Pasamar, Sara / Cortés, José R / Perona, Almudena / Abia, David / Blanco, Soledad / Fuentes, Manuel / Arellano, Irene / Lobo, Juan / Heidarieh, Haleh / Rueda, Javier / Esteve, Pilar / Cibrián, Danay / Martinez-Riaño, Ana / Mendoza, Pilar /
    Prieto, Cristina / Calleja, Enrique / Oeste, Clara L / Orfao, Alberto / Fresno, Manuel / Sánchez-Madrid, Francisco / Alcamí, Antonio / Bovolenta, Paola / Martín, Pilar / Villoslada, Pablo / Morreale, Antonio / Messeguer, Angel / Alarcon, Balbino

    Science translational medicine

    2016  Volume 8, Issue 370, Page(s) 370ra184

    Abstract: Modulating T cell activation is critical for treating autoimmune diseases but requires avoiding concomitant opportunistic infections. Antigen binding to the T cell receptor (TCR) triggers the recruitment of the cytosolic adaptor protein Nck to a proline- ... ...

    Abstract Modulating T cell activation is critical for treating autoimmune diseases but requires avoiding concomitant opportunistic infections. Antigen binding to the T cell receptor (TCR) triggers the recruitment of the cytosolic adaptor protein Nck to a proline-rich sequence in the cytoplasmic tail of the TCR's CD3ε subunit. Through virtual screening and using combinatorial chemistry, we have generated an orally available, low-molecular weight inhibitor of the TCR-Nck interaction that selectively inhibits TCR-triggered T cell activation with an IC
    Language English
    Publishing date 2016-12-21
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2518854-9
    ISSN 1946-6242 ; 1946-6234
    ISSN (online) 1946-6242
    ISSN 1946-6234
    DOI 10.1126/scitranslmed.aaf2140
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top